Calcification and Vascular Cell Differentiation
钙化和血管细胞分化
基本信息
- 批准号:6964145
- 负责人:
- 金额:$ 38.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:atherosclerosisblood vessel disordercalcificationcalcium disordercalcium metabolismcell differentiationchronic renal failureenzyme activitygenetically modified animalslaboratory mousemitogen activated protein kinaseosteochondritispathologic processphosphatesphosphorus metabolismvascular smooth muscle
项目摘要
DESCRIPTION (provided by applicant): Vascular calcification is highly correlated with cardiovascular disease (CVD) mortality, especially in end stage renal disease (ESRD) and diabetic patients. In addition to the devastating effects of inappropriate biomineralization seen in cardiac valvulopathies, calciphylaxis and idiopathic infantile arterial calcification, vascular calcification is now recognized as a marker of atherosclerotic plaque burden as well as a major contributor to loss of arterial compliance and increased pulse pressure seen with age, diabetes and renal insufficiency. Whether or not vascular calcification can cause or exacerbate atherosclerosis is not known, and will be addressed in this proposal. Furthermore, arterial wall cells appear to play a particularly important role in mediating vascular calcification, especially in situations where osteochondral tissue is observed, such as in atherosclerosis and medial calcification associated with ESRD. This proposal seeks to identify the origins of the cells participating in osteochondral tissue formation, and mechanisms controlling their differentiation. These studies will aid in the development of novel therapeutic strategies to prevent and potentially reverse vascular calcification, an urgent need in the ESRD population.
描述(申请人提供):血管钙化与心血管疾病(CVD)死亡率高度相关,特别是在终末期肾病(ESRD)和糖尿病患者中。除了心脏瓣膜病、钙质疏松症和特发性婴儿动脉钙化中不适当的生物矿化的破坏性影响外,血管钙化现在被认为是动脉粥样硬化斑块负担的标志,也是随着年龄、糖尿病和肾功能不全而导致动脉顺应性丧失和脉压增加的主要因素。血管钙化是否会引起或加重动脉粥样硬化尚不清楚,将在本提案中讨论。此外,动脉壁细胞似乎在介导血管钙化方面发挥着特别重要的作用,特别是在观察到骨软骨组织的情况下,如动脉粥样硬化和与终末期肾病相关的内侧钙化。这一建议试图确定参与骨软骨组织形成的细胞的起源,以及控制其分化的机制。这些研究将有助于开发新的治疗策略来预防并有可能逆转血管钙化,这是终末期肾病患者的迫切需要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cecilia M Giachelli其他文献
Cecilia M Giachelli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cecilia M Giachelli', 18)}}的其他基金
Mechanisms of vascular and valvular calcification
血管和瓣膜钙化的机制
- 批准号:
10548126 - 财政年份:2018
- 资助金额:
$ 38.88万 - 项目类别:
Mechanisms of vascular and valvular calcification
血管和瓣膜钙化的机制
- 批准号:
10321921 - 财政年份:2018
- 资助金额:
$ 38.88万 - 项目类别:
Role of Osteoclastogenesis in Calcific Aortic Valve Disease
破骨细胞生成在钙化性主动脉瓣疾病中的作用
- 批准号:
8535810 - 财政年份:2012
- 资助金额:
$ 38.88万 - 项目类别:
Role of Osteoclastogenesis in Calcific Aortic Valve Disease
破骨细胞生成在钙化性主动脉瓣疾病中的作用
- 批准号:
8351281 - 财政年份:2012
- 资助金额:
$ 38.88万 - 项目类别:
Role of Osteoclastogenesis in Calcific Aortic Valve Disease
破骨细胞生成在钙化性主动脉瓣疾病中的作用
- 批准号:
8697123 - 财政年份:2012
- 资助金额:
$ 38.88万 - 项目类别:
Vascular Matrix Biology and Bioengineering Workshop
血管基质生物学与生物工程研讨会
- 批准号:
7614577 - 财政年份:2009
- 资助金额:
$ 38.88万 - 项目类别: